GlaxoSmithKline Inc News

large-cap U.K. firms, such as HSBC and Vodafone, have strong and well-established operations in the faster-growing emerging markets. GlaxoSmithKline (GSK) and AstraZeneca (AZN), which carry wide moat ratings, are able to maintain their competitive advantages

PLC (GSK) - Director/PDMR Shareholding (Replacement) RNS Number : 7997D GlaxoSmithKline PLC 21 May 2012  This announcement replaces the original announcement released on 11 May 2012 at 15.25 (RNS No: 2041D) Due to an administrative error by the Administrators

6:40:29 AM PHILADELPHIA , May 21, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and GlaxoSmithKline LLC, the U.S. subsidiary of GlaxoSmithKline plc (LSE: GSK), announced today that they have entered into an agreement for the co-promotion

2012 because of plans to start co-promoting its testosterone gel Testim in the U.S. this summer with British pharmaceutical giant GlaxoSmithKline plc. Glaxo will get the right to jointly sell Testim with Auxilium in the United States through 2015, the companies

and is absorbed into the bloodstream, with the intention that it would help return testosterone to normal levels. “Today, GlaxoSmithKline and Auxilium have forged a collaboration to expand our reach to U.S. physicians who treat men with low testosterone and

is considering an appeal. GlaxoSmithKline (NYSE:GSK) subsidiary Stiefel Labotories must pay a former employee $1.5 million, according to a jury verdict awarded in a stock buyback case. If other verdicts go that way — including a Securities and Exchange Commission

GlaxoSmithKline and Auxilium have forged a collaboration to expand our reach to U.S. physicians who treat men with low testosterone and its resulting symptoms, known as hypogonadism, which we believe is a prevalent, but poorly recognized condition," said Adrian

scientific instruments, agreed on Thursday to buy Dako, a Danish cancer diagnostics company, for $2.2 billion. The British drugmaker GlaxoSmithKline also is attempting to acquire the biotechnology company Human Genome Sciences for $2.6 billion. DaVita said

that it received US FDA approval of Ropinirole Extended-Release Tablets, 2mg, 4mg, 6mg, 8mg and 12mg, a generic equivalent to GlaxoSmithKline's Requip® XL. Actavis believes this is the first generic Requip® XL available in the US. Distribution of the product

Genome Sciences Inc.'s ( HGSI ) board of directors has advised its stockholders to reject GlaxoSmithKline's ( GSK ) tender offer. The offer to acquire all outstanding common shares of Human Genome for $ 13.00 per share was considered inadequate by the board.